Who
Christopher Michael Lyons
Director
Company insider
Files Form 4 as: Director, SiNtx Technologies.
In numbers
- Trades disclosed
- 4
- Buys
- 2
- Sells
- 0
- Bought
- $48K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 25 Feb 2026
- Last trade
- 2 Mar 2026
- Last filed
- 10 Mar 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 10 Mar 2026 | SINT SiNtx TechnologiesMedical Devices | SEC FORM 4 Bought | $22K7,534 at $2.90 | filing |
| 2 Mar 2026filed 10 Mar 2026 | SINT SiNtx TechnologiesMedical Devices | SEC FORM 4 Bought | $22K7,534 at $2.90 | filing |
| 25 Feb 2026filed 10 Mar 2026 | SINT SiNtx TechnologiesMedical Devices | SEC FORM 4 Bought | $2,244758 at $2.96 | filing |
| 25 Feb 2026filed 10 Mar 2026 | SINT SiNtx TechnologiesMedical Devices | SEC FORM 4 Bought | $2,244758 at $2.96 | filing |
News
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and WebcastSINT · manilatimes.net · 22 Oct 2026
0 headlines in the last 90 days name Christopher Michael Lyons; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.